Pr Camille Laurent

Identification of immuno-escapement mechanisms by multiomics approaches.

After his discovery of phosphoantigens, Jean-Jacques Fournié, team director until 2021, founded the concept of anti-tumor immunotherapy by Tγδ cells and has been interested throughout his career in the treatment of lymphomas. Recently, he introduced Single-Cell RNAseq techniques at the CRCT and developed bioinformatics tools for the multidimensional analysis of individual tumor cells and their microenvironment, including the immune system. His current work combines scRNAseq, CITEseq, and Spatial transcriptomics to understand and treat immune escape in patients with B-cell lymphomas as well as other solid cancers.

Parternships and funding:

 

Labex Toucan